Differential effects of transient treatment of spontaneously hypertensive rats with various antihypertensive agents on the subsequent development of diabetic nephropathy

Kimiko Ishiguro, Hiroyuki Sasamura, Yusuke Sakamaki, Kaori Hayashi, Takao Saruta, Hiroshi Itoh

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background/Aims: We have previously shown that treatment of spontaneously hypertensive rats (SHR) with an angiotensin receptor blocker (ARB) during the 'critical period' from age 3 to 10 weeks confers protection against L-NAME-induced renal injury later in life. The aim of this study was to examine the effects of transient prepubertal exposure to ARB on the development of nephropathy in streptozotocin-induced diabetic SHR and to compare the results with other antihypertensive agents including a mineralocorticoid receptor antagonist (MR-ant). Methods: Male SHR (n = 43) were transiently treated with candesartan (ARB), potassium canreonate (the active metabolite of the MR-ant spironolactone) or hydralazine (vasodilator) between 3 and 10 weeks of age with untreated rats serving as controls. An additional group was treated continuously with candesartan throughout the study. Rats were injected with streptozotocin to induce diabetes at age 16 weeks and followed until age 8 months. Results: Diabetic control rats showed signs of diabetic nephropathy including albuminuria and mesangial expansion. These changes were significantly suppressed in rats exposed to ARB or MR-ant. Systolic blood pressure was significantly reduced compared to controls in the ARB (transient) and ARB (sustained) groups, but not in the MR-ant or vasodilator groups. Conclusion: Transient prepubertal exposure to ARB or MR-ant, but not vasodilator, confers protection against the later development of diabetic nephropathy and involves blood pressure-independent protective mechanisms.

Original languageEnglish
JournalNephron - Experimental Nephrology
Volume109
Issue number1
DOIs
Publication statusPublished - 2008 Jun

Fingerprint

Angiotensin Receptor Antagonists
Diabetic Nephropathies
Inbred SHR Rats
Mineralocorticoid Receptor Antagonists
Antihypertensive Agents
Vasodilator Agents
Streptozocin
Blood Pressure
Hydralazine
Spironolactone
Albuminuria
NG-Nitroarginine Methyl Ester
Potassium
Kidney
Wounds and Injuries

Keywords

  • Diabetic nephropathy
  • Spontaneously hypertensive rats
  • Streptozotocin
  • Transient antihypertensive treatment

ASJC Scopus subject areas

  • Nephrology

Cite this

Differential effects of transient treatment of spontaneously hypertensive rats with various antihypertensive agents on the subsequent development of diabetic nephropathy. / Ishiguro, Kimiko; Sasamura, Hiroyuki; Sakamaki, Yusuke; Hayashi, Kaori; Saruta, Takao; Itoh, Hiroshi.

In: Nephron - Experimental Nephrology, Vol. 109, No. 1, 06.2008.

Research output: Contribution to journalArticle

@article{7b4cef974caf421aa4f4267b1ebaab16,
title = "Differential effects of transient treatment of spontaneously hypertensive rats with various antihypertensive agents on the subsequent development of diabetic nephropathy",
abstract = "Background/Aims: We have previously shown that treatment of spontaneously hypertensive rats (SHR) with an angiotensin receptor blocker (ARB) during the 'critical period' from age 3 to 10 weeks confers protection against L-NAME-induced renal injury later in life. The aim of this study was to examine the effects of transient prepubertal exposure to ARB on the development of nephropathy in streptozotocin-induced diabetic SHR and to compare the results with other antihypertensive agents including a mineralocorticoid receptor antagonist (MR-ant). Methods: Male SHR (n = 43) were transiently treated with candesartan (ARB), potassium canreonate (the active metabolite of the MR-ant spironolactone) or hydralazine (vasodilator) between 3 and 10 weeks of age with untreated rats serving as controls. An additional group was treated continuously with candesartan throughout the study. Rats were injected with streptozotocin to induce diabetes at age 16 weeks and followed until age 8 months. Results: Diabetic control rats showed signs of diabetic nephropathy including albuminuria and mesangial expansion. These changes were significantly suppressed in rats exposed to ARB or MR-ant. Systolic blood pressure was significantly reduced compared to controls in the ARB (transient) and ARB (sustained) groups, but not in the MR-ant or vasodilator groups. Conclusion: Transient prepubertal exposure to ARB or MR-ant, but not vasodilator, confers protection against the later development of diabetic nephropathy and involves blood pressure-independent protective mechanisms.",
keywords = "Diabetic nephropathy, Spontaneously hypertensive rats, Streptozotocin, Transient antihypertensive treatment",
author = "Kimiko Ishiguro and Hiroyuki Sasamura and Yusuke Sakamaki and Kaori Hayashi and Takao Saruta and Hiroshi Itoh",
year = "2008",
month = "6",
doi = "10.1159/000135386",
language = "English",
volume = "109",
journal = "Experimental Nephrology",
issn = "1660-8151",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Differential effects of transient treatment of spontaneously hypertensive rats with various antihypertensive agents on the subsequent development of diabetic nephropathy

AU - Ishiguro, Kimiko

AU - Sasamura, Hiroyuki

AU - Sakamaki, Yusuke

AU - Hayashi, Kaori

AU - Saruta, Takao

AU - Itoh, Hiroshi

PY - 2008/6

Y1 - 2008/6

N2 - Background/Aims: We have previously shown that treatment of spontaneously hypertensive rats (SHR) with an angiotensin receptor blocker (ARB) during the 'critical period' from age 3 to 10 weeks confers protection against L-NAME-induced renal injury later in life. The aim of this study was to examine the effects of transient prepubertal exposure to ARB on the development of nephropathy in streptozotocin-induced diabetic SHR and to compare the results with other antihypertensive agents including a mineralocorticoid receptor antagonist (MR-ant). Methods: Male SHR (n = 43) were transiently treated with candesartan (ARB), potassium canreonate (the active metabolite of the MR-ant spironolactone) or hydralazine (vasodilator) between 3 and 10 weeks of age with untreated rats serving as controls. An additional group was treated continuously with candesartan throughout the study. Rats were injected with streptozotocin to induce diabetes at age 16 weeks and followed until age 8 months. Results: Diabetic control rats showed signs of diabetic nephropathy including albuminuria and mesangial expansion. These changes were significantly suppressed in rats exposed to ARB or MR-ant. Systolic blood pressure was significantly reduced compared to controls in the ARB (transient) and ARB (sustained) groups, but not in the MR-ant or vasodilator groups. Conclusion: Transient prepubertal exposure to ARB or MR-ant, but not vasodilator, confers protection against the later development of diabetic nephropathy and involves blood pressure-independent protective mechanisms.

AB - Background/Aims: We have previously shown that treatment of spontaneously hypertensive rats (SHR) with an angiotensin receptor blocker (ARB) during the 'critical period' from age 3 to 10 weeks confers protection against L-NAME-induced renal injury later in life. The aim of this study was to examine the effects of transient prepubertal exposure to ARB on the development of nephropathy in streptozotocin-induced diabetic SHR and to compare the results with other antihypertensive agents including a mineralocorticoid receptor antagonist (MR-ant). Methods: Male SHR (n = 43) were transiently treated with candesartan (ARB), potassium canreonate (the active metabolite of the MR-ant spironolactone) or hydralazine (vasodilator) between 3 and 10 weeks of age with untreated rats serving as controls. An additional group was treated continuously with candesartan throughout the study. Rats were injected with streptozotocin to induce diabetes at age 16 weeks and followed until age 8 months. Results: Diabetic control rats showed signs of diabetic nephropathy including albuminuria and mesangial expansion. These changes were significantly suppressed in rats exposed to ARB or MR-ant. Systolic blood pressure was significantly reduced compared to controls in the ARB (transient) and ARB (sustained) groups, but not in the MR-ant or vasodilator groups. Conclusion: Transient prepubertal exposure to ARB or MR-ant, but not vasodilator, confers protection against the later development of diabetic nephropathy and involves blood pressure-independent protective mechanisms.

KW - Diabetic nephropathy

KW - Spontaneously hypertensive rats

KW - Streptozotocin

KW - Transient antihypertensive treatment

UR - http://www.scopus.com/inward/record.url?scp=46349106647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46349106647&partnerID=8YFLogxK

U2 - 10.1159/000135386

DO - 10.1159/000135386

M3 - Article

C2 - 18506109

AN - SCOPUS:46349106647

VL - 109

JO - Experimental Nephrology

JF - Experimental Nephrology

SN - 1660-8151

IS - 1

ER -